With six sites in Germany (Berlin, Gauting, Grafing, Neu-Ulm, and Waltrop) and France (Sophia Antipolis), along with local experts in Latin America, NUVISAN has a 40-year track record of partnering with our biotech startup, pharma, nonprofit, and venture capitalist clients to find solutions to their needs—from target identification to the patient.
More than 70% of our drug discovery and development team holds a science degree (> 30% scientists, > 70% of whom hold PhDs, and about 40% lab professionals). Our scientific staff offers an interdisciplinary blend of industry-experienced scientists and young talent from academic institutions across the globe. Thanks to more than 1,000 employees, we know how to discover, develop, and bring to market the next generation of medicines. At the same time, our scientists understand that every project is different. With a flexible and innovative approach and transparent communication, our teams are passionate about closely collaborating with you to adapt to your individual needs.